People | June 29, 2022
DTx Pharma appoints Peter Condon as Chief Business Officer
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Silo enters into commercial evaluation license agreement for next generation liposomes
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
Subscribe To Our Newsletter & Stay Updated
